Likewise’s Tony Brewer on accelerating growth, strong investment and £200m+ revenue ambition 4 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP 4 February 2026
Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum 2 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
Time Finance Delivers Positive Interim Results, Signals Confidence for Future Growth – Cavendish 28 January 2026
Unite Group PLC (UTG.L) Stock Analysis: Evaluating Potential Upside with a Robust 6.49% Dividend Yield 23 February 2026
United Utilities Group PLC (UU.L): Navigating Utility Investments with a 3.91% Dividend Yield 23 February 2026
Rightmove PLC (RMV.L) Stock Analysis: Understanding the 41.54% Potential Upside and Key Metrics 23 February 2026
Spirax Group PLC (SPX.L) Stock Analysis: Navigating an Industrial Powerhouse with a 0.08% Potential Upside 23 February 2026
SEGRO PLC (SGRO.L) Stock Analysis: Exploring Growth Potential in Industrial Real Estate 23 February 2026
Likewise’s Tony Brewer on accelerating growth, strong investment and £200m+ revenue ambition 4 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP 4 February 2026
Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum 2 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
Time Finance Delivers Positive Interim Results, Signals Confidence for Future Growth – Cavendish 28 January 2026
Unite Group PLC (UTG.L) Stock Analysis: Evaluating Potential Upside with a Robust 6.49% Dividend Yield 23 February 2026
United Utilities Group PLC (UU.L): Navigating Utility Investments with a 3.91% Dividend Yield 23 February 2026
Rightmove PLC (RMV.L) Stock Analysis: Understanding the 41.54% Potential Upside and Key Metrics 23 February 2026
Spirax Group PLC (SPX.L) Stock Analysis: Navigating an Industrial Powerhouse with a 0.08% Potential Upside 23 February 2026
SEGRO PLC (SGRO.L) Stock Analysis: Exploring Growth Potential in Industrial Real Estate 23 February 2026
Ardent Health, Inc. (ARDT) Stock Analysis: A 52.11% Potential Upside with a Strong Buy Consensus 3 February 2026
Indivior Pharmaceuticals (INDV) Stock Analysis: A 30% Upside Opportunity Amidst Promising Drug Innovations 3 February 2026
Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Uncovering the 9.51% Potential Upside 3 February 2026
Progyny, Inc. (PGNY) Stock Analysis: Healthcare Innovator Offers 27.67% Potential Upside 3 February 2026
Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring a 5.72% Potential Upside 3 February 2026
Clover Health Investments, Corp (CLOV): Investor Outlook on a 46.97% Potential Upside 3 February 2026
MiMedx Group, Inc. (MDXG) Stock Analysis: Unpacking a 104% Potential Upside for Investors 3 February 2026
Belite Bio, Inc (BLTE) Stock Analysis: Strong Buy Ratings and Promising Clinical Pipeline Signal Growth Potential 3 February 2026
Healthcare Services Group, Inc. (HCSG) Stock Analysis: Evaluating an 11.8% Potential Upside 3 February 2026
Recursion Pharmaceuticals (RXRX) Stock Analysis: Biotech Innovator with 67% Potential Upside 3 February 2026
Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 177.99% Upside in the Diagnostics and Pharmaceuticals Sector 3 February 2026
Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Navigating Growth with a Promising Revenue Surge in the Healthcare Sector 3 February 2026
Apogee Therapeutics, Inc. (APGE) Stock Analysis: A 58.9% Potential Upside for Investors in the Biotech Sector 3 February 2026
Travere Therapeutics (TVTX): Investor Outlook Highlights 27% Potential Upside in Biotech Sector 3 February 2026
Mesoblast Limited (MESO) Stock Analysis: Unpacking the 103% Potential Upside in Regenerative Medicine 3 February 2026
Metsera, Inc. (MTSR) Stock Analysis: A Clinical-Stage Biotech with Limited Growth Potential 3 February 2026
Veracyte, Inc. (VCYT) Investor Outlook: Exploring a 24.91% Potential Upside in the Diagnostics Sector 3 February 2026
Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring a 32% Upside Potential 3 February 2026
Xenon Pharmaceuticals (XENE) Stock Analysis: A Biotech Gem with 33.91% Upside Potential 3 February 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
RM plc Unlocking the Future of Global Assessment with Scalable AI and Digital Exams (Video) 21 January 2026
The Renewables Infrastructure Group delivers 2025 dividend target despite Q4 NAV decline 16 February 2026
Likewise’s Tony Brewer on accelerating growth, strong investment and £200m+ revenue ambition 4 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP 4 February 2026
Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum 2 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
Time Finance Delivers Positive Interim Results, Signals Confidence for Future Growth – Cavendish 28 January 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Unite Group PLC (UTG.L) Stock Analysis: Evaluating Potential Upside with a Robust 6.49% Dividend Yield 23 February 2026
United Utilities Group PLC (UU.L): Navigating Utility Investments with a 3.91% Dividend Yield 23 February 2026
Rightmove PLC (RMV.L) Stock Analysis: Understanding the 41.54% Potential Upside and Key Metrics 23 February 2026
Spirax Group PLC (SPX.L) Stock Analysis: Navigating an Industrial Powerhouse with a 0.08% Potential Upside 23 February 2026
SEGRO PLC (SGRO.L) Stock Analysis: Exploring Growth Potential in Industrial Real Estate 23 February 2026
